Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

I C U Medical Inc (ICUI)

I C U Medical Inc (ICUI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

I C U Medical Inc 951 CALLE AMANECER SAN CLEMENTE CA 92763 USA

www.icumed.com P: 949-366-2183 F: 949-366-8368

Description:

ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels.

Key Statistics

Overview:

Market Capitalization, $K 2,356,582
Enterprise Value, $K 3,731,132
Shares Outstanding, K 24,365
Annual Sales, $ 2,259 M
Annual Net Income, $ -29,660 K
Last Quarter Sales, $ 587,860 K
Last Quarter Net Income, $ -17,150 K
EBIT, $ 22,820 K
EBITDA, $ 258,430 K
60-Month Beta 0.69
% of Insider Shareholders 6.70%
% of Institutional Shareholders 96.10%
Float, K 22,733
% Float 93.30%
Short Volume Ratio 0.37

Growth:

1-Year Return -47.55%
3-Year Return -53.56%
5-Year Return -58.15%
5-Year Revenue Growth 61.36%
5-Year Earnings Growth -28.66%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 1.57 on 02/27/24
Latest Earnings Date 05/07/24
Earnings Per Share ttm 5.50
EPS Growth vs. Prev Qtr 0.81%
EPS Growth vs. Prev Year -8.82%
Annual Dividend Yield 0.00%
Most Recent Dividend 1.500 on 03/18/02
Dividend Payout Ratio 0.00%
Most Recent Split 3-2 on 03/18/02

ICUI Ratios

Ratio
Price/Earnings ttm 17.77
Price/Earnings forward 27.41
Price/Earnings to Growth N/A
Return-on-Equity % 6.35%
Return-on-Assets % 3.03%
Profit Margin % -1.31%
Debt/Equity 0.77
Price/Sales 1.05
Price/Cash Flow 6.29
Price/Book 1.10
Book Value/Share 87.96
Interest Coverage -0.18

ICUI Dividends

Date Value
03/18/02 $1.5000
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar